South Africa vs Uzbekistan: Prevalence rate of hypertension in women aged 30-79
South Africa
44.3
in 2019
Uzbekistan
44.6
in 2019
South Africa rank
26th
Uzbekistan rank
24th
Prevalence rate of hypertension in women aged 30-79 over time
- South Africa
- Uzbekistan
How they compare
Uzbekistan currently reports 44.6 against 44.3 in South Africa, a difference of 0.3.
The two have swapped places 2 times across 30 shared years of data; in 1990 it was Uzbekistan ahead.
South Africa ranks 26th and Uzbekistan ranks 24th of 195 countries.
South Africa has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | South Africa | Uzbekistan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 37.54 | 35.64 | 1.9 | South Africa |
| 2000s | 44.11 | 37.38 | 6.73 | South Africa |
| 2010s | 45.91 | 42.44 | 3.47 | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, South Africa or Uzbekistan?
- Uzbekistan, at 44.6 against 44.3 in South Africa as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between South Africa and Uzbekistan?
- 0.3, with Uzbekistan ahead.
- How many years of comparable data are there for South Africa and Uzbekistan?
- 30 years are reported by both, from 1990 to 2019.
- How do South Africa and Uzbekistan rank globally for prevalence rate of hypertension in women aged 30-79?
- South Africa ranks 26th and Uzbekistan ranks 24th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.